Clinical Trial Update: Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating entecavir to prevent hepatitis B reinfection after liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: HepNet Study House, German Liverfoundation | Conditions: Liver Transplantation, Hepatitis B | Phase 3 | Status: COMPLETED